Suchergebnisse - "Darunavir"

PubPharm (1.758)

1

Machine learning-guided design of potent darunavir analogs targeting HIV-1 proteases : A computational approach for antiretroviral drug discovery

enthalten in: Journal of computational chemistry | 2024

von Chuntakaruk, H. | Boonpalit, K. | Kinchagawat, J. | +8

2

Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Mulato, A. | Lansdon, E. | Aoyama, R. | +24

3

Different effects of the companion antiretroviral drugs on dolutegravir trough concentrations

enthalten in: AIDS (London, England) | 2024

von Cattaneo, D. | Pagano, S. | Colombo, M. | +3

4

Enteral administration of crushed rilpivirine in a patient with HIV : A case report

enthalten in: British journal of clinical pharmacology | 2024

von Ragonnet, G. | Laroche, H. | Néant, N. | +5

5

Rational design, synthesis and biological evaluation of novel HIV-1 protease inhibitors containing 2-phenylacetamide derivatives as P2 ligands with potent activity against DRV-Resistant HIV-1 variants

enthalten in: Bioorganic & medicinal chemistry letters | 2024

von Meng, S. | Gao, Y. | Qiang, G. | +5

6

Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy : 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT)

enthalten in: EClinicalMedicine | 2024

von Paton, N. | Stöhr, W. | Arenas-Pinto, A. | +112

7

FMO-guided design of darunavir analogs as HIV-1 protease inhibitors

enthalten in: Scientific reports | 2024

von Chuntakaruk, H. | Hengphasatporn, K. | Shigeta, Y. | +5

8

Plasma Concentrations of Rosmarinic Acid in Patients on Antiretroviral Therapy : In Silico Exploration Based on Clinical Data

enthalten in: International journal of molecular sciences | 2024

von Hitl, M. | Pavlović, N. | Brkić, S. | +3

9

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1 : week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

enthalten in: The lancet. HIV | 2024

von Orkin, C. | Molina, J. | Cahn, P. | +112

10

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents : a substudy of the SMILE trial

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Abdalla, S. | Compagnucci, A. | Riault, Y. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[176]